AAMU
Amundi Asset Management US Portfolio holdings
AUM
$131B
1-Year Return
73.56%
This Quarter Return
+7.36%
1 Year Return
+73.56%
3 Year Return
+96.82%
5 Year Return
+179.26%
10 Year Return
–
AUM
$131B
AUM Growth
+$13.1B
(+11%)
Cap. Flow
+$6.14B
Cap. Flow
% of AUM
4.7%
Top 10 Holdings %
Top 10 Hldgs %
19.26%
Holding
1,593
New
120
Increased
673
Reduced
527
Closed
74
Top Buys
| 1 |
Stellantis
STLA
|
$883M |
| 2 |
Microsoft
MSFT
|
$373M |
| 3 |
Schlumberger
SLB
|
$371M |
| 4 |
NVIDIA
NVDA
|
$331M |
| 5 |
Danaher
DHR
|
$319M |
Top Sells
| 1 |
Bank of America
BAC
|
$372M |
| 2 |
Hartford Financial Services
HIG
|
$294M |
| 3 |
Verizon
VZ
|
$257M |
| 4 |
Apple
AAPL
|
$255M |
| 5 |
Marvell Technology
MRVL
|
$246M |
Sector Composition
| 1 | Technology | 22.45% |
| 2 | Consumer Discretionary | 14.8% |
| 3 | Healthcare | 13.32% |
| 4 | Financials | 12.63% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
1301
DELISTED
Allakos
ALLK
| $344K | ﹤0.01% |
3,000
| – | – |
|
1302
Mercury Systems
MRCY
$4.13B
| $342K | ﹤0.01% |
4,846
-4,326
| -47% | -$305K |
|
1303
Twist Bioscience
TWST
$1.55B
| $341K | ﹤0.01% |
2,753
-1,247
| -31% | -$154K |
|
|
ONEM
1304
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $340K | ﹤0.01% |
8,700
| – | – |
|
1305
LivaNova
LIVN
$3.17B
| $339K | ﹤0.01% |
+4,600
| New | +$339K |
|
1306
Pilgrim's Pride
PPC
$10.5B
| $336K | ﹤0.01% |
14,118
-11,701
| -45% | -$278K |
|
1307
National Beverage
FIZZ
$3.75B
| $335K | ﹤0.01% |
6,851
-2,149
| -24% | -$105K |
|
1308
New Fortress Energy
NFE
$672M
| $335K | ﹤0.01% |
+7,300
| New | +$335K |
|
|
ARNA
1309
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $333K | ﹤0.01% |
4,800
| – | – |
|
1310
Vir Biotechnology
VIR
$732M
| $332K | ﹤0.01% |
6,475
-10,536
| -62% | -$540K |
|
1311
Ambarella
AMBA
$3.54B
| $331K | ﹤0.01% |
+3,300
| New | +$331K |
|
1312
LivePerson
LPSN
$89.9M
| $331K | ﹤0.01% |
6,279
-1,200
| -16% | -$63.3K |
|
1313
SPS Commerce
SPSC
$4.19B
| $330K | ﹤0.01% |
3,324
-2,200
| -40% | -$218K |
|
1314
Acadia Healthcare
ACHC
$2.19B
| $329K | ﹤0.01% |
5,751
-2,849
| -33% | -$163K |
|
1315
Home BancShares
HOMB
$5.88B
| $329K | ﹤0.01% |
12,152
-3,848
| -24% | -$104K |
|
|
NUVA
1316
DELISTED
NuVasive, Inc.
NUVA
| $328K | ﹤0.01% |
5,000
| – | – |
|
1317
Celsius Holdings
CELH
$15B
| $327K | ﹤0.01% |
+20,400
| New | +$327K |
|
1318
MarineMax
HZO
$568M
| $324K | ﹤0.01% |
6,564
-4,551
| -41% | -$225K |
|
1319
Descartes Systems
DSGX
$9.26B
| $323K | ﹤0.01% |
5,316
-207
| -4% | -$12.6K |
|
1320
STAAR Surgical
STAA
$1.38B
| $318K | ﹤0.01% |
3,018
-1,673
| -36% | -$176K |
|
1321
Werner Enterprises
WERN
$1.71B
| $316K | ﹤0.01% |
6,700
| – | – |
|
1322
Amkor Technology
AMKR
$6.09B
| $315K | ﹤0.01% |
+13,300
| New | +$315K |
|
|
BPMC
1323
DELISTED
Blueprint Medicines
BPMC
| $314K | ﹤0.01% |
3,231
-1,069
| -25% | -$104K |
|
1324
Apellis Pharmaceuticals
APLS
$3.55B
| $313K | ﹤0.01% |
7,300
| – | – |
|
1325
Kinsale Capital Group
KNSL
$10.6B
| $313K | ﹤0.01% |
1,900
| – | – |
|